Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ANAB
ANAB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ANAB News
AnaptysBio Approves Spin-Off of First Tracks Biotherapeutics
3d ago
seekingalpha
AnaptysBio Announces $100 Million Buyback and Business Update
3d ago
NASDAQ.COM
Anaptys Announces Spin-Off of Biopharma Operations
3d ago
Newsfilter
First Tracks Biotherapeutics Secures $145 Million in Private Placement Financing
3d ago
Newsfilter
First Tracks Biotherapeutics Spin-Off Date Set
3d ago
Newsfilter
ANAPTYSBIO INC - AJIM TAMBOLI LIKELY TO BE NAMED CFO OF FIRST TRACKS BIO
3d ago
moomoo
ANAPTYSBIO INC TO SEPARATE BIOPHARMA OPERATIONS INTO FIRST TRACKS BIOTHERAPEUTICS ON APRIL 20, 2026
3d ago
moomoo
AnaptysBio Q4 Earnings Exceed Expectations
Mar 03 2026
seekingalpha
AnaptysBio Options Trading Analysis
Mar 03 2026
NASDAQ.COM
Vanda Pharmaceuticals Files BLA for Imsidolimab to Treat GPP
Feb 25 2026
PRnewswire
Vanda Pharmaceuticals Files BLA for Imsidolimab to Treat GPP
Feb 25 2026
Newsfilter
Anaptysbio Biotech Stock Breaks Trendline
Feb 03 2026
Yahoo Finance
AnaptysBio Director Sells 3,900 Shares for $193,342.50
Jan 12 2026
NASDAQ.COM
AnaptysBio Director Sells 3,900 Shares for $193,342.50
Jan 12 2026
Fool
AnaptysBio CMO Paul Lizzul Sells 3,650 Shares for $163,191.50
Jan 11 2026
NASDAQ.COM
AnaptysBio CMO Sells 3,650 Shares for $163,191.50
Jan 11 2026
Fool
Show More News
